AmandaMccraryRosecransMD

Physician

Dr. Rosecrans is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1717 E Monument St
Baltimore, MD 21287
Phone+1 410-955-1725

Fax+1 410-500-4266

Johns Hopkins University/Bayview Medical CenterResidency, Internal Medicine, 2013 - 2016
University of Maryland School of MedicineClass of 2013

PubMed

Redefining low-threshold buprenorphine access in an integrated mobile clinic program: Factors associated with treatment retention.
Robert Harris, Norberth Stracker, Molly Rice, Anne St Clair, Kathleen Page
Journal of Substance Use and Addiction Treatment. 2024-11-29
6 citations
Proviral location affects cognate peptide-induced virus production and immune recognition of HIV-1-infected T cell clones.
Filippo Dragoni, Abena K Kwaa, Caroline C Traut, Rebecca T Veenhuis, Bezawit A Woldemeskel
The Journal of Clinical Investigation. 2023-11-01
22 citations
Mobile low-threshold buprenorphine integrated with infectious disease services.
Amanda Rosecrans, Robert E. Harris, Ronald E. Saxton, Margaret Cotterell, Meredith Zoltick
Journal of Substance Abuse Treatment. 2021-06-24

Abstinence Not Required: How a Baltimore Drug Treatment Program Prioritizes Saving LivesJune 14th, 2023